About Innoforce

Innoforce is a partnership-focused biopharmaceutical company established to enable and accelerate the innovation of breakthrough ATMPs and Biologics. Innoforce offers end-to-end contract development and manufacturing service (CDMO), including GMP manufacturing of plasmid DNA, RNA, viral vector and cell products. In addition, through a joint venture with a leading international supplier of life sciences products and services, the company provides CDMO services for antibody and protein drugs. Innoforce’s capabilities for incubating and developing cell, gene and advanced biological therapies companies to rapidly and efficiently bring cutting-edge treatments that impact patients’ lives worldwide.